Bausch + Lomb

Yahoo Finance • 22 days ago

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

VAUGHAN, Ontario, December 23, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunde... Full story

Yahoo Finance • last month

Cooper Cos. jumps after starting strategic review, naming new board chair

[CooperVision headquarters in East San Francisco Bay Area] Sundry Photography/iStock Editorial via Getty Images Cooper Cos. (COO [https://seekingalpha.com/symbol/COO]) soared 12% in after hours trading after initiating a strategic review... Full story

Yahoo Finance • last month

BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point?

Key Points Connecticut-based Silver Point Capital added nearly 2.6 million BLCO shares in the third quarter, increasing its 13F portfolio by about $38.7 million. The transaction represents 2.8% of reportable U.S. equity assets under manag... Full story

Yahoo Finance • last month

Stocks making the biggest moves midday: Maplebear, Boeing, Credo Technology, XPO, MongoDB & more

Check out the companies making the biggest moves midday: Maplebear — The parent company of Instacart fell nearly 4% after Amazon said it's testing "ultra-fast" delivery of groceries in Seattle and Philadelphia. These deliveries take about... Full story

Yahoo Finance • last month

Stocks making the biggest moves premarket: MongoDB, Strategy, Signet Jewelers, Credo and more

Check out the companies making the biggest moves in premarket trading: MongoDB — Shares of the developer data platform soared 24% following strong third-quarter results. Adjusted earnings were $1.32 per share on revenue of $628 million, co... Full story

Yahoo Finance • last month

3 Small-Cap Stocks with Warning Signs

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it ha... Full story

Yahoo Finance • 2 months ago

Catalyst Watch: Eyes on Cisco and Disney earnings, 13F filings

[Financial stock market graph. Selective focus.] Diego Thomazini/iStock via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may... Full story

Yahoo Finance • 3 months ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Interest Rate Cut Hopes

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Koya Medical Honored by Goldman Sachs for Entrepreneurship

Koya Medical CEO Andy Doraiswamy Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit DALLAS, Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recognizing Koya Medical ("Koya") CEO Andy Doraiswam... Full story

Yahoo Finance • 4 months ago

Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers

Bausch + Lomb recently announced positive results from a study on XIIDRA, enhancing its position in treating dry eye disease in contact lens wearers. This news, alongside the U.S. launch of ASANA gas permeable lenses and improved Q2 earnin... Full story

Yahoo Finance • 5 months ago

Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know

What Happened? Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the afternoon session after comments from Federal Reserve Chair Jerome Powell raised investor hopes for future interest rate cuts. The move came as U.S. sto... Full story

Yahoo Finance • 5 months ago

Icahn representations resign Bausch + Lomb board after agreement termination

(Reuters) -Contact lens maker Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire investor Carl Icahn and some of his affiliates. The agree... Full story

Yahoo Finance • 5 months ago

Bausch Health rises after $300M worth insider purchase

[Bausch Health US headquarters in Bridgewater, NJ, USA.] JHVEPhoto/iStock Editorial via Getty Images Bausch Health (NYSE:BHC [https://seekingalpha.com/symbol/BHC]) shares added ~4% on Friday after John Paulson, a board member of the Canad... Full story

Yahoo Finance • 5 months ago

Howard Marks Reduces Stake in Garrett Motion Inc, Impacting Portfolio by -1.4%

Insightful Moves in the Second Quarter of 2025 Howard Marks (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. As the Chairman of Oaktree... Full story

Yahoo Finance • 5 months ago

Bausch + Lomb’s SWOT analysis: ophthalmology leader faces spin-off uncertainty

Bausch + Lomb Corporation (NYSE:BLCO, TSX:BLCO), a prominent player in the healthcare sector specializing in ophthalmology, has been navigating a complex landscape of market opportunities and corporate challenges. With a market capitalizat... Full story

Yahoo Finance • 5 months ago

Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story

Yahoo Finance • 6 months ago

Bausch Lomb (BLCO) Q2 Revenue Rises 5%

Key Points Revenue (GAAP) rose 5% year over year to $1.28 billion, surpassing expectations by $18 million. Adjusted EPS (non-GAAP) came in at $0.07, above the $0.06 consensus but down sharply from last year's $0.13. Net loss narrowed to $... Full story

Yahoo Finance • 6 months ago

Bausch + Lomb raises 2025 revenue guidance to $5.15B as dry eye and contact lens growth accelerate

Earnings Call Insights: Bausch + Lomb (BLCO) Q2 2025 MANAGEMENT VIEW * CEO Brenton L. Saunders reported "our constant currency revenue growth speaks to the breadth and depth of our portfolio and is driven by a mix of hero products and... Full story

Yahoo Finance • 6 months ago

Stock Index Futures Muted as Investors Await U.S. GDP Data and Fed Rate Decision, Microsoft and Meta Earnings on Tap

Trader at NYSE by Orhan Akkurt via Shutterstock September S&P 500 E-Mini futures (ESU25) are up +0.04%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are up +0.10% this morning, pointing to a cautious open on Wall Street as investors awa... Full story

Yahoo Finance • 6 months ago

Bausch + Lomb Announces Publication Of Phase 3 Results On LUMIFY Preservative Free

(RTTNews) - Bausch + Lomb Corporation (BLCO) Tuesday said results from a Phase 3 study showed that LUMIFY Preservative Free is non inferior to LUMIFY redness reliever eye drops for reducing redness in the eyes. In the study, participants... Full story